Search form

You are here

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Purdue Pharma, the producer of OxyContin, recently announced it would end physician-directed marketing of all opioids. The move is a step forward in efforts to control misuse and abuse of opioids in the U.S., but, according to physicians in Maine, it comes two decades too late.

Liz O’Riordan, as consultant oncoplastic breast surgeon in the U.K., has spent her entire career removing cancer from others. But after being diagnosed with stage 3 breast cancer in July 2015, she found herself on the other side of the equation.

The University of California, San Francisco (UCSF) received a $500 million commitment from the Helen Diller Foundation to help plan and build a new hospital, according to a Feb. 8 release from the university.

Purdue Pharma, best known for making and selling OxyContin, announced Feb. 10 that it will stop marketing opioid drugs to physicians. The company also stated it will lay off half of its sales force, with the remaining staff of 200 focusing on other medications.

President Donald Trump is expected to release a budget proposal Monday, Feb. 12. This move is more of a wish list from the chief executive, because Congress controls federal spending, but the budget can convey priorities and policy ideas.

Medicaid patients face a host of challenges in accessing care, with reliable, timely transportation often being a major consideration. A recently published study, though, showed rates of missed primary care appointments were unaffected when Medicaid patients were offered free ridesharing services.

The democratizing power of technology is undeniable—it has put a world of information into a person’s pocket or purse. Cardiac ultrasound, however, isn’t exactly top of mind for technologies that will be the next DIY sensation. But one nonprofit plans to introduce a handheld imaging device to increase availability of ultrasound while reducing costs.

The democratizing power of technology is undeniable—as it has put a world of information into a person’s pocket or purse. Cardiac ultrasound, however, isn’t exactly top of mind for technologies that will be the next DIY sensation. But one nonprofit plans to introduce a handheld imaging device to increase availability of ultrasound while reducing costs.

As healthcare costs outpace inflation, patients are more and more cost-conscious—with many often shopping around to minimize out-of-pocket costs—but medicine remains far from transparent. A recent story from WBRC in Birmingham, Alabama, explored one man’s shock when he received an $8,000 bill for two MRIs on his back.

Exposure to noise pollution has been shown to negatively impact cardiovascular health. But researchers have only recently begun to explore exactly how noise can harm health. A study published online Feb. 6 in the Journal of the American College of Cardiology explored the connection between noise and arterial hypertension, myocardial infarction, heart failure and stroke.